Planet Labs PBC (PL) Guidance & Earnings Results

On 2026-09-03 Planet Labs PBC raised guidance: "Q3 FY2027 revenue $101-105M; Q3 FY2027 non-GAAP gross margin 56-58%; Q3 FY2027 adjusted EBITDA loss ($6)-($1)M; Q3 FY2027 capex $30-37M. FY2027 revenue $430-441M; FY2027 non-GAAP gross margin 55-57%; FY2027 adjusted…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason

PLPlanet Labs PBCFollow PL — free

Aerospace & Defense · Industrials

—

Price chart with a free account

Market cap: 4.9B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 8 Dec, in 44 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
3 Sep 26	Raised	Q3 FY2027 revenue $101-105M; Q3 FY2027 non-GAAP gross margin 56-58%; Q3 FY2027 adjusted EBITDA loss ($6)-($1)M; Q3 FY2027 capex $30-37M. FY2027 revenue $430-441M; FY2027 non-GAAP gross margin 55-57%; FY2027 adjusted EBITDA profit $3-10M; FY2027 capex $100-115M.
19 Mar 26	Raised	Project strong growth for this year and beyond; leaning in and investing. · full year
8 Sep 25	Raised	Record revenue, strong backlog, positive free cash flow

Planet Labs PBC — questions

What guidance did Planet Labs PBC give?: On 2026-09-03: "Q3 FY2027 revenue $101-105M; Q3 FY2027 non-GAAP gross margin 56-58%; Q3 FY2027 adjusted EBITDA loss ($6)-($1)M; Q3 FY2027 capex $30-37M. FY2027 revenue $430-441M; FY2027 non-GAAP gross margin 55-57%; FY2027 adjusted EBITDA profit $3-10M; FY2027 capex $100-115M."
When does Planet Labs PBC report earnings?: Planet Labs PBC's next earnings report is expected on 2026-12-08.

Every figure on this page comes from Planet Labs PBC's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.